Michael I Webb

发表

Merging the chemistry of electron-rich olefins with imidazolium ionic liquids: radicals and hydrogen-atom adducts

I. McKenzie, C. Sherren, Changhua Mu, 2011 .

Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR

Michael I Webb, C. Walsby, Joshua A. Dubland, 2010, JBIC Journal of Biological Inorganic Chemistry.

Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions.

Michael I Webb, C. Walsby, Bo Wu, 2013, Chemistry.

Albumin binding and ligand-exchange processes of the Ru(III) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy.

Michael I Webb, C. Walsby, 2015, Dalton transactions.

Direct observation of activated hydrogen binding to a supported organometallic compound at room temperature.

T. Yildirim, J. Simmons, Michael I Webb, 2012, Chemistry.

Pyridine analogues of the antimetastatic Ru(III) complex NAMI-A targeting non-covalent interactions with albumin.

Michael I Webb, C. Walsby, R. Chard, 2012, Inorganic chemistry.

Ruthenium(II)–arene complexes with chelating quinoline ligands as anti-amyloid agents

Michael I Webb, Paige J Bothwell, Cade J. Meiss, 2021, Canadian Journal of Chemistry.

Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(III) complex NAMI-A by interactions with human serum albumin.

Michael I Webb, C. Walsby, 2011, Dalton transactions.

Class III delocalization and exciton coupling in a bimetallic bis-ligand radical complex.

Michael J. Katz, Michael I Webb, T. Storr, 2013, Chemistry.

Stabilization of different redox levels of a tridentate benzoxazole amidophenoxide ligand when bound to Co(iii) or V(v).

Michael I Webb, T. Storr, C. Walsby, 2019, Dalton transactions.

Double oxidation localizes spin in a Ni bis-phenoxyl radical complex.

Michael I Webb, T. Storr, T. J. Dunn, 2013, Dalton transactions.

Non-innocent ligand behaviour of a bimetallic Cu complex employing a bridging catecholate.

Michael I Webb, T. Storr, T. Ogura, 2012, Dalton transactions.

Arylspiroborates Derived from 4-tert-Butylcatechol and 3,5-Di-tert-butylcatechol and Their Antimicrobial Activities

C. A. Gray, Michael I Webb, N. Halcovitch, 2014 .

A Ru(II)-arene-ferrocene complex with promising antibacterial activity.

C. Hamaker, Michael I Webb, G. Ferrence, 2022, Dalton transactions.

Design and synthesis of vanadium hydrazide gels for Kubas-type hydrogen adsorption: a new class of hydrogen storage materials.

T. Hoang, Michael I Webb, C. Walsby, 2010, Journal of the American Chemical Society.

High metal substitution tolerance of anthrax lethal factor and characterization of its active copper-substituted analogue.

Michael I Webb, C. Walsby, S. Siemann, 2014, Journal of inorganic biochemistry.

Importance of Hydrogen Bonding: Structure-Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer's Disease Therapy.

David C. Platt, Michael I Webb, Marjorie A. Jones, 2021, Journal of medicinal chemistry.

EPR as a probe of the intracellular speciation of ruthenium(III) anticancer compounds.

Michael I Webb, C. Walsby, 2013, Metallomics : integrated biometal science.

Ruthenium(III) complexes with imidazole ligands that modulate the aggregation of the amyloid-β peptide via hydrophobic interactions.

David C. Platt, C. Hamaker, Michael I Webb, 2020, Journal of inorganic biochemistry.

Ruthenium(iii) complexes containing thiazole-based ligands that modulate amyloid-β aggregation.

David C. Platt, C. Hamaker, Michael I Webb, 2020, Metallomics : integrated biometal science.

A Dual-Pronged Approach: A Ruthenium(III) Complex That Modulates Amyloid-β Aggregation and Disrupts Its Formed Aggregates.

David C. Platt, C. Hamaker, Michael I Webb, 2022, Inorganic chemistry.

Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity.

Changhua Mu, Michael I Webb, T. Storr, 2015, Metallomics : integrated biometal science.

Spectroscopic studies of the physiological speciation of ruthenium(iii) anticancer complexes

Michael I Webb, 2013 .

Finding the best location: Improving the anti-amyloid ability of ruthenium(III) complexes with pyridine ligands.

Michael I Webb, P. Bothwell, Johanna T. Ehlbeck, 2023, Journal of inorganic biochemistry.